Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 323 - Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
Patents for C07C 323 - Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups (27,160)
10/2002
10/22/2002US6469005 Propargylether derivatives
10/22/2002US6468999 Treating anxiety, depression and other central nervous system disorders in humans and animals
10/22/2002US6468667 Covalently linking to the material surface specific carbohydrates which mimic a biological surface for durability, hydrophilicity, wettability and biocompatibility; contact lens
10/22/2002CA2073084C The use of sulphur-containing carboxylic acids to combat physiologically-induced excitatory disorders and diseases related thereto as well as allergic diseases and also the preparation of corresponding medicaments
10/17/2002WO2002082185A1 Perfluoroalkylsulfonic acid compounds for photoresists
10/17/2002WO2002081464A1 Benzoaxathiepin derivatives and their use as medicines
10/17/2002WO2002081454A1 Derivatives of aryl acids, their use in medicine, process for their preparation and pharmaceutical compositions containing them
10/17/2002WO2002081432A2 Sulfoxides or sulfones grafted onto polymers
10/17/2002WO2002081424A2 Chemical compounds derived from octopamine and their uses as beta 3-adrenergic agonists
10/17/2002WO2002049967A3 Novel multidentate sulfur-containing ligands
10/17/2002US20020151669 Polyisocyanate compounds, process for producing the same, and optical materials using the same
10/17/2002US20020151580 Synthetic spiroketal pyranes as potent anti-cancer agents and use
10/17/2002US20020151546 HIV protease inhibitors based on amino acid derivatives
10/17/2002US20020151529 Bile-acid derived compounds for providing sustained systemic concentrations of drugs after oral administration
10/17/2002DE10114970A1 New 1,2-diamino-4-azolyl-, -4-furyl-, -4-thienyl-, -4-phenyl- and -4-azinyl-benzene compounds and known analogues are used in oxidative colorants for keratin fibers, especially human hair
10/17/2002DE10104770C1 (1,1'-Biphenyl)-2,4-diamin-Derivate enthaltende Färbemittel für Keratinfasern sowie neue (1,1'-Biphenyl)-2,4-diamin-Derivate (1,1'-biphenyl) -2,4-diamine derivatives containing a colorant for keratin fibers and new (1,1'-biphenyl) -2,4-diamine derivatives
10/16/2002EP1249446A2 Use of thio derivates as perfuming and flavoring ingredients
10/16/2002EP1249233A1 Npyy5 antagonists
10/16/2002EP0934316B1 Azabicyclic carbamoyloxy mutilin derivatives for antibacterial use
10/16/2002EP0869938B1 Novel vinyl sulfide compounds and a process for their preparation
10/16/2002EP0542136B1 1-[(1,4-benzodioxanyl)alkyl]-4-(heteroaryl) piperidines, piperazines and pyrrolidines as antipsychotic agents
10/16/2002EP0538477B1 Novel cyclic aminophenylacetic acid derivative, production thereof, and immune response modulator containing the same as active ingredient
10/16/2002CN1374940A O-Anisamide derivatives
10/16/2002CN1374288A Gronwell naphthaquinone derivative and its application in preparing anticancer medicine
10/16/2002CN1092700C Sulfurized phenolic antioxidant composition, method of preparing same, and petroleum products containing the same
10/15/2002US6465694 Method for preparation of polyethylene glycol aldehyde derivatives
10/15/2002US6465663 Ethyl (e)-4-(2-(5,6-dihydro-5,5-dimethyl-naphthalen-8(7h)-one-2 -yl)ethenyl)benzoate and ethyl (e)-4-(2-(5,6-dihydro-5,5-dimethyl-8-(phenylthio)-naphthalenyl)ethenyl) benzoate
10/15/2002US6465457 Carbonate, carbamate, thiocarbonate dithiocarbonate and thiocarbomate derivatives useful as fungicides
10/15/2002US6465178 Reagent for covalent attachment of nucleic acids onto the surface of the substrate, comprising a polymer backbone having pendant thermochemically reactive groups; making activated slides for use in microarrays
10/15/2002US6464895 Reagent and process which are useful for grafting a substituted difluoromethyl group onto a compound containing at least one electrophilic function
10/15/2002CA2112690C Amino acid derivative
10/10/2002WO2003084997A1 Probes, systems and methods for drug discovery
10/10/2002WO2002079143A1 N-phenpropylcyclopentyl-substituted glutaramide derivatives as nep inhibitors for fsad
10/10/2002WO2002079122A2 Methods of synthesizing phenol-containing compounds
10/10/2002WO2002078693A2 N-(2-arylethyl)benzylamines as antagonists of the 5-ht6 receptor
10/10/2002US20020147342 Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase and tace inhibitors
10/10/2002US20020147234 Nitrate esters and methods of making same
10/10/2002US20020147191 Antiinflammatory agents, psychological disorders
10/10/2002CA2442654A1 Probes, systems, and methods for drug discovery
10/10/2002CA2442480A1 Methods of synthesizing phenol-containing compounds
10/10/2002CA2437113A1 N-phenpropylcyclopentyl-substituted glutaramide derivatives as nep inhibitors for fsad
10/09/2002EP1246795A2 Antibacterial agents
10/09/2002EP1246625A2 Methods and compositions for mitigating pain using nitrate esters
10/09/2002EP1246621A1 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
10/09/2002EP0863857B1 Perfluoroalkylation method and reagent therefor
10/09/2002EP0679082B1 C10 taxane derivatives and pharmaceutical compositions
10/09/2002CN1373751A 'Alpha'-amino-'beta'-sulfonyl hydroxamic acid compounds
10/09/2002CN1373745A 3-amino-2-benzyl-1-phenyl-propane derivs.
10/09/2002CN1092184C Processes for preparation of 3-(methylthio) propanal
10/08/2002US6462240 Froming 2-lithiobenzotrifloride from benzotrifluoride and alkyllithium
10/08/2002US6462092 Such as 3-((3-fluorophenyl)-((3-(trifluoromethyl)phenyl)-methyl)amino)-1,1,1 -trifluoro-2-propanol; cardiovascular disease, i.e. atherosclerosis and other coronary artery diseases
10/08/2002US6462076 Beta-amino acid nitrile derivatives as cathepsin K inhibitors
10/08/2002US6462073 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
10/08/2002US6461664 Chelated feed additive and method of preparation
10/08/2002CA2036643C Sulfur-containing esters as synergists of amine and phenolic antioxidants
10/08/2002CA2027446C Cyclohexenone compounds and their use as herbicides or plant growth regulators
10/03/2002WO2002076962A1 Process for producing 3-oxo-2-(2-thiazolyl)propanenitrile and intermediate
10/03/2002WO2002076939A2 Cysteine protease inhibitors
10/03/2002WO2002076935A1 Novel a-lipoic acid derivative and use thereof
10/03/2002WO2002076925A2 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
10/03/2002WO2002076395A2 Agents and methods for treatment of cancer
10/03/2002WO2002030880A3 N-substituted amino acid derivatives (factor xa inhibitors)
10/03/2002US20020143205 Reacting pivaloyl chloride with hydroxyketosulfide compound and trialkylamine in the presence of a catalyst in a substantially non-reactive solvent to form ketoester sulfide compound; oxidizing to form ketoester sulfone compound
10/03/2002US20020143187 Nitric oxide donors and pharmaceutical compositions containing them
10/03/2002US20020143186 For prophylaxis and therapy of hyperglycemia, Type 1 diabetes, Type 2 diabetes, disorders of the lipid metabolism, such as dyslipidemia, and obesity
10/03/2002US20020143177 For inhibiting beta-secretase enzyme activity and A beta peptide production, inhibition of beta-secretase enzyme activity halts or reduces production of A beta from APP and reduces or eliminates the formation of beta-amyloid deposits
10/03/2002US20020143036 Pentafluorobenzenesulfonamides and analogs
10/03/2002US20020143003 As serotonin, norepinephrine and dopamine reuptake inhibitors, for therapy of central nervous system and other disorders
10/03/2002US20020142998 For prophylaxis and therapy
10/03/2002US20020142947 By muta-synthesis using a mutated micro-organism to influence the biosynthesis of at least one of the precursors of group B streptogramines; mutant strain employed is preferably derived from the strain S. pristinaespiralis SP92
10/03/2002CA2441394A1 Agents and methods for treatment of cancer
10/03/2002CA2441080A1 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
10/02/2002EP1245404A1 Thermographic recording material providing prints with good image density and tone having improved archivability
10/02/2002EP1245249A2 Use of a cationic amphipathic compound as a transfection agent, vaccine additive or drug
10/02/2002CN1372542A Thioglycerol derivatives and their use in polysulfide compositions for optical material
10/02/2002CN1372539A Quaternary bis-ammonium salt precursors and their uses as prodrugs having an antiparasitic activity
10/02/2002CN1371603A Cyclopropene supply system
10/02/2002CN1091766C Prenyl transferase inhibitors
10/01/2002US6458997 Continuous hydrolysis process for the preparation of 2-hydroxy-4-methylthiobutanoic acid
10/01/2002US6458965 Herbicides, antigrowth agents and surfactants for wood preservatives
10/01/2002US6458948 Process for producing carboxylic acid derivative and condensing agent comprising quaternary ammonium salt
10/01/2002US6458908 A process for preparing a sulfur-containing unsaturated carboxylate compound as claimed in claim 1 comprising reacting a sulfur-containing derivative for optical polymers
10/01/2002US6458852 Use of substituted N, N-bis-phenyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity
10/01/2002US6458849 Method of treating or preventing a ceip-mediated disorder in a subject by administering a therapeutically effective amount of a compound for strokes
10/01/2002US6458803 Substituted N-phenyl-N-heteroaralkyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity
10/01/2002US6458779 Treatment of conditions associated with excess production of soluble cd23 (s-cd23) such as autoimmune disease and allergy. the compounds of the invention are also inhibitors of the release of tumour necrosis factor (tnf).
10/01/2002US6458775 NAALADase inhibitors useful as pharmaceutical compounds and compositions
09/2002
09/26/2002WO2002074736A1 New diaminedithiol derivatives and radiorhenium or radiotechnetium complex thereof; a liver cancer-treating composition comprising the radiorhenium complex and lipiodol; and a kit for preparation of the liver cancer-treating composition
09/26/2002WO2002074298A1 Il-6 production inhibitors
09/26/2002WO2002074296A1 Remedies for solid cancer containing hydroxamic acid derivatives as the active ingredient
09/26/2002WO2002028810A3 Retinoids for the treatment of emphysema
09/26/2002WO2002024636A3 N-acylsulfonamide apoptosis promoters
09/26/2002WO2000071785A3 2-cylcoalkylcarbonylcyclohexane-1,3-dione derivatives as herbicides
09/25/2002EP1243577A1 Novel phenylalanine derivatives
09/25/2002EP1242365A1 Acyl pseudodipeptides which carry a functionalised auxiliary arm
09/25/2002EP1242364A1 Adamantane derivatives
09/25/2002EP1242070A2 Treatment of ischemic brain injuries with brain targetted antioxidant compounds
09/25/2002EP0986529B1 Process for the preparation of 1,3-dicarbonyl compounds
09/25/2002CN1371357A Aminobenzoic acid derivatives
09/25/2002CN1091446C Colchicine derivatives, use thereof and formulations containing them
1 ... 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 ... 272